Neurological Biomarkers Market to Surge with Early Alzheimer’s Detection
Technological Neurological Biomarkers Market Demand advancements shape market dynamics by integrating artificial intelligence, machine learning, and multi-omics approaches. Innovations in single-molecule detection, high-resolution imaging, and lab-on-a-chip platforms enhance analytical sensitivity and throughput. Market research underscores a shift toward decentralized testing models and real-time monitoring, which open up market opportunities for point-of-care devices and cloud-enabled diagnostics.

The neurological biomarkers market encompasses a broad range of diagnostic assays, imaging markers, and molecular indicators designed to detect, monitor, and predict neurological diseases. These products include cerebrospinal fluid tests, blood-based assays, positron emission tomography (PET) tracers, and genomic panels that pinpoint protein aggregates, genetic mutations, or metabolic changes associated with conditions such as Alzheimer’s, Parkinson’s, and multiple sclerosis.

Neurological Biomarkers Market

https://www.coherentmarket...

#NeurologicalBiomarkers ,#DiagnosticInnovation,#NeurodegenerativeDiseases,#PersonalizedMedicine,#BiotechDiagnostics,#CoherentmarketInsights.